3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Lung Neoplasms
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Wilms Tumor
1
Venous Thromboembolism
1
Uveal Melanoma
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Smoking Cessation
1
Recurrence
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Neoplastic Cells, Circulating
1
Motor Activity
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Hepatic Veno-Occlusive Disease
1
HPV Positive Oropharyngeal Squamous Cell Carcinoma
1
Fibrosis
1
Esophageal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Blood Specimen Collection
3
Surveys and Questionnaires
2
Practice Guidelines as Topic
1
Methods
1
Magnetic Resonance Spectroscopy
1
Lasers, Semiconductor
1
Hyperthermia, Induced
1
Hematologic Tests
1
Health Promotion
1
Focus Groups
1
Exercise
1
Educational Status
1
Cytidine Diphosphate Choline
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Uveal Melanoma
×
Hematologic Tests
×
Clear all
NCT04424719
2025-09-03
SALOME
Institut Curie
Phase NA
Recruiting
700 enrolled